Michael Wehrli

Kantonsspital Winterthur

Papers

1

Total Citations

3

H-Index

1

About

Michael Wehrli is a colorectal surgeon whose research centers on advancing surgical techniques for rectal cancer, particularly through transanal total mesorectal excision (taTME). His major contribution lies in rigorously evaluating the safety, efficacy, and long-term outcomes of taTME for distal rectal cancer—a minimally invasive approach designed to improve margin clearance. In his landmark prospective cohort study of 165 patients, Wehrli demonstrated that taTME achieves favorable surgical outcomes with acceptable recurrence rates, providing critical evidence to counter concerns about high complications that led to a temporary moratorium in some countries. This work, with 3 citations, directly informs ongoing debates about optimal surgical standards. Beyond this, Wehrli’s research addresses resource utilization and recurrence patterns, helping surgeons balance innovation with patient safety. His findings have shaped clinical protocols and offer reassurance for adopting taTME in carefully selected cases. For students and researchers, Wehrli exemplifies how meticulous outcomes analysis can validate emerging techniques and guide evidence-based practice in oncologic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Surgical Outcomes, Long-Term Recurrence Rate and Resource Utilization in a Prospective Cohort of 165 Patients Treated by Transanal Total Mesorectal Excision for Distal Rectal Cancer
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Kantonsspital Winterthur

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago